Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Express Scripts

Generated: December 13, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076730

« Back to Dashboard

NDA 076730 describes ALCLOMETASONE DIPROPIONATE, which is a drug marketed by Fougera Pharms, Glenmark Generics, and Taro, and is included in six NDAs. It is available from five suppliers. Additional details are available on the ALCLOMETASONE DIPROPIONATE profile page.

The generic ingredient in ALCLOMETASONE DIPROPIONATE is alclometasone dipropionate. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the alclometasone dipropionate profile page.

Summary for 076730

Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)

Pharmacology for NDA: 076730

Suppliers and Packaging for NDA: 076730

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALCLOMETASONE DIPROPIONATE alclometasone dipropionate OINTMENT;TOPICAL 076730 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1316 51672-1316-3 1 TUBE in 1 CARTON (51672-1316-3) > 60 g in 1 TUBE
ALCLOMETASONE DIPROPIONATE alclometasone dipropionate OINTMENT;TOPICAL 076730 ANDA Taro Pharmaceuticals U.S.A., Inc. 51672-1316 51672-1316-5 5 g in 1 TUBE (51672-1316-5)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;TOPICALStrength0.05%
Approval Date:Jul 29, 2004TE:ABRLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: